LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,070,000 | +2.7% | 143,640 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $1,042,000 | -17.8% | 149,885 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $1,267,000 | +6.5% | 153,980 | +4.8% | 0.00% | 0.0% |
| Q2 2016 | $1,190,000 | +59.3% | 146,954 | -0.0% | 0.00% | 0.0% |
| Q1 2016 | $747,000 | -34.2% | 147,023 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,135,000 | +27.5% | 147,023 | -4.8% | 0.00% | 0.0% |
| Q3 2015 | $890,000 | -27.0% | 154,517 | +16.2% | 0.00% | 0.0% |
| Q2 2015 | $1,219,000 | – | 132,956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 5,604,015 | $67,865,000 | 99.40% |
| Avoro Capital Advisors LLC | 2,149,907 | $26,035,000 | 9.99% |
| ACUTA CAPITAL PARTNERS, LLC | 669,196 | $8,104,000 | 6.83% |
| Perceptive Advisors | 2,714,549 | $32,873,000 | 2.56% |
| Opaleye Management Inc. | 200,000 | $2,422,000 | 1.12% |
| Broadfin Capital, LLC | 1,062,419 | $12,866,000 | 1.00% |
| QVT Financial LP | 1,325,000 | $16,046,000 | 0.89% |
| Ghost Tree Capital, LLC | 400,000 | $4,844,000 | 0.87% |
| Cormorant Asset Management, LP | 424,815 | $5,145,000 | 0.80% |
| P.A.W. CAPITAL CORP | 65,000 | $787,000 | 0.78% |